Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$3.22 +0.28 (+9.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Prepaid Assets (2018 - 2025)

Scinai Immunotherapeutics (SCNI) posted Prepaid Assets of $170000.0 for Q4 2025, down 27.97% sequentially from $236000.0 in Q2 2025, and down 20.19% YoY from $213000.0 in Q4 2024.

Scinai Immunotherapeutics (SCNI) Prepaid Assets (2018 - 2025) Analysis & Trends

Scinai Immunotherapeutics has reported Prepaid Assets for 6 years, with the latest figure at $170000.0 in Q4 2025.

  • Quarterly Prepaid Assets fell 20.19% year-over-year to $170000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $170000.0 (down 20.19% YoY) and the FY2025 annual result came in at $170000.0, down 20.19% from the prior year.
  • Prepaid Assets eased to $170000.0 in Q4 2025 per SCNI's latest filing, from $236000.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $437000.0 in Q4 2023 and troughed at $119000.0 in Q1 2023.
  • A 5-year average of $224333.3 and a median of $213000.0 in 2024 frame the typical range for Prepaid Assets.
  • The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 181.94% in 2023, then sank 51.26% in 2024.
  • Over 5 years, Prepaid Assets stood at $227000.0 in 2021, then slumped by 31.72% to $155000.0 in 2022, then jumped by 181.94% to $437000.0 in 2023, then tumbled by 51.26% to $213000.0 in 2024, then decreased by 20.19% to $170000.0 in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $170000.0, $236000.0, and $213000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Scinai Immunotherapeutics 11.72 Mn -3.10 Bn -1.12 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 170,000.00
Jun 30, 2025 236,000.00
Dec 31, 2024 213,000.00
Jun 30, 2024 324,000.00
Dec 31, 2023 437,000.00
Jun 30, 2023 138,000.00
Mar 31, 2023 119,000.00
Dec 31, 2022 155,000.00
Dec 31, 2021 227,000.00
Dec 31, 2018 156,000.00